Praxis Precision Medicines, Inc.
- Stock
- Ticker PRAX
- Nasdaq
Performance, volatility and drawdowns of Praxis Precision Medicines, Inc. since 10/2020, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $9,629. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −98.7% in 03/2023, measured from the peak in 01/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 7.5 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – |
| Operating income | -64 | -75 | -76 | -78 | -97 | -106 | -97 | -107 |
| EBITDA | -64 | -75 | -76 | -78 | -97 | -106 | -97 | -107 |
| Net income | -59 | -69 | -71 | -74 | -89 | -93 | -84 | -94 |
| Earnings per share | -3.00 | -3.29 | -3.31 | -3.36 | -3.51 | -3.20 | -2.87 | -3.23 |
| Balance sheet | ||||||||
| Total assets | 483 | 479 | 453 | 396 | 938 | 1,460 | 1,390 | 1,312 |
| Liabilities | 38 | 40 | 49 | 53 | 60 | 50 | 49 | 52 |
| Equity | 445 | 439 | 404 | 344 | 878 | 1,410 | 1,341 | 1,260 |
| Cash | 215 | 166 | 157 | 150 | 357 | 536 | 475 | 362 |
| Cash flow | ||||||||
| Operating cash flow | -56 | -53 | -55 | -65 | -76 | -86 | -78 | -82 |
| Capital expenditure | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | -0.1 | -0.2 | -1.6 |
| Free cash flow | -56 | -53 | -55 | -65 | -76 | -86 | -78 | -83 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +283.0%, weakest 2022 at −87.9%. 2 of 5 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 9 Nov 2026 | −$3.23 |
| 6 Aug 2026 | −$2.87 |
| 7 May 2026 | −$3.20 |
| 19 Feb 2026 | −$3.51 |
| 5 Nov 2025 | −$3.36 |
| 4 Aug 2025 | −$3.31 |
| 2 May 2025 | −$3.29 |
| 28 Feb 2025 | −$3.00 |
| 6 Nov 2024 | −$2.75 |
| 13 Aug 2024 | −$1.74 |
| 13 May 2024 | −$2.84 |
| 5 Mar 2024 | −$1.96 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €7.6bn
- Market cap in trading currency
- $8.40bn
- Enterprise value
- $7.65bn
- P/E
- –
- P/S
- –
- P/B
- 6.67
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -3.9%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- −$407m
- Net income
- −$359m
- Earnings per share
- −$12.81
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- -44.8%
- Return on assets
- -27.4%
Balance sheet and cash flow
- Cash
- $745m
- Cash per share
- $26.66
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 14.53
- Book value per share
- $45.06
- Operating cash flow
- −$322m
- Free cash flow
- −$324m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 28.0m
- Volume
- 794,095
- Avg. volume 3 months
- 459,470
- Relative volume
- 1.7
Price and technicals
- Price
- $300.43
- 1 day
- −3.4%
- 52-week high
- $386.33
- 52-week low
- $164.09
- Distance to 52-week high
- −22.2%
- Distance to 52-week low
- +83.1%
- Distance to 50-day line
- +5.0%
- Distance to 200-day line
- −4.5%
- RSI (14)
- 51
- Volatility 1M
- 88.6%
Performance
- 1 week
- −8.4%
- 1 month
- +16.0%
- 3 months
- −18.4%
- 6 months
- −12.6%
- YTD
- +1.9%
- 1 year
- +58.7%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has PRAX performed since 10/2020?
$10,000 grew to $7,205 by 20 Nov 2026, which is −5.2% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is PRAX?
Volatility was 150.0% per year, measured on monthly returns. The largest decline from a peak was −98.7%, with the low in 03/2023.
How does PRAX compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.2% volatility, PRAX returned −5.2% at 150.0%. The correlation of monthly returns was 0.26; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.